The percentage of TILs and the degree of TLSs within HR+/HER2− tissue were significantly lower than those in HR−/HER2+ or HR−/HER2− triple-negative breast cancer (TNBC) subtypes (Figure 1A and 1B). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.